These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 14973998)

  • 21. Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials.
    Palmer SC; Tunnicliffe DJ; Singh-Grewal D; Mavridis D; Tonelli M; Johnson DW; Craig JC; Tong A; Strippoli GFM
    Am J Kidney Dis; 2017 Sep; 70(3):324-336. PubMed ID: 28233655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for renal vasculitis in adults.
    Walters G; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD003232. PubMed ID: 18646089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
    Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
    Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treating lupus nephritis: guideline from the Italian Society of Nephrology].
    Stratta P; Canavese C; Lupo A; Pozzi C; Passerini P; Cagnoli L; Manno C; Strippoli GF;
    G Ital Nefrol; 2007; 24 Suppl 37():S50-63. PubMed ID: 17347955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.
    Holdgate A; Pollock T
    Cochrane Database Syst Rev; 2005 Apr; 2004(2):CD004137. PubMed ID: 15846699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
    Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
    Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
    Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002290. PubMed ID: 15846634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
    Strippoli GF; Manno C; Schena FP; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of lupus nephritis: a meta-analysis of clinical trials.
    Bansal VK; Beto JA
    Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory agents for idiopathic pulmonary fibrosis.
    Davies HR; Richeldi L; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.